NDC : 51655 - 875 - 25 MFG : 53489 - 676 - 10 Phentermine HCL 37 . 5 MG C IV 60 tablets Rx only Lot # : Exp .
Date : Each tablet contains : Phentermine hydrochloride , USP .... 37 . 5 mg Dosage : See package insert Store at 68 to 77 degrees F . Store in a tight , light - resistance container ( See USP ) Keep out of the reach of children .
Mfg by : Mutual Pharmaceuticals Co . , Inc Philadelphia , PA 19124 Lot # Distributed by : Northwind Pharmaceuticals , Indianapolis , IN 46256 [ MULTIMEDIA ] NDC : 51655 - 875 - 90 Phentermine HCL 37 . 5 MG C IV 45 Tablets Rx Only Lot : Exp : Store at 20 C to 25 C ( 68 - 77 F ) Manufactured by Mutual Pharmaceuticals Co Inc Manufacture Address : Philadelphia , PA 19124 Manufacture NDC : 53489 - 676 - 10 Mfg Lot : 6677501 Distributed by : Northwind Pharmaceuticals Indianapolis , IN 46256 [ MULTIMEDIA ] NDC : 51655 - 875 - 24 Phentermine HCL 37 . 5 MG C IV 30 Tablets Rx Only Lot : Exp : Store at 20 C to 25 C ( 68 - 77 F ) Manufactured by Mutual Pharmaceuticals Co Inc Manufacture Address : Philadelphia , PA 19124 Manufacture NDC : 53489 - 676 - 10 Mfg Lot : 6677501 Distributed by : Northwind Pharmaceuticals Indianapolis , IN 46256 [ MULTIMEDIA ] NDC : 51655 - 875 - 25 Phentermine HCL 37 . 5 MG C IV 60 Tablets Rx Only Lot : Exp : Store at 20 C to 25 C ( 68 - 77 F ) Manufactured by Mutual Pharmaceuticals Co Inc Manufacture Address : Philadelphia , PA 19124 Manufacture NDC : 53489 - 676 - 10 Mfg Lot : 6677501 Distributed by : Northwind Pharmaceuticals Indianapolis , IN 46256 [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] Indications and Usage Phentermine hydrochloride is a sympathomimetic amine anorectic indicated as a short - term adjunct ( a few weeks ) in a regimen of weight reduction based on exercise , behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥ 30 kg / m2 , or ≥ 27 kg / m2 in the presence of other risk factors ( e . g . , controlled hypertension , diabetes , hyperlipidemia ) .
( 1 ) The limited usefulness of agents of this class , including phentermine hydrochloride , should be measured against possible risk factors inherent in their use Dosage and Administration Dosage should be individualized to obtain an adequate response with the lowest effective dose .
Late evening administration should be avoided ( risk of insomnia ) .
Phentermine hydrochloride tablets can be taken with or without food Contraindications History of cardiovascular disease ( e . g . , coronary artery disease , stroke , arrhythmias , congestive heart failure , uncontrolled hypertension ) During or within 14 days following the administration of monoamine oxidase inhibitors Hyperthyroidism Glaucoma Agitated states History of drug abuse Pregnancy Nursing Known hypersensitivity , or idiosyncrasy to the sympathomimetic amines Warning and Precautions Coadministration with other drugs for weight loss is not recommended ( safety and efficacy of combination not established ) .
Rare cases of primary pulmonary hypertension have been reported .
Phentermine should be discontinued in case of new , unexplained symptoms of dyspnea , angina pectoris , syncope or lower extremity edema .
Rare cases of serious regurgitant cardiac valvular disease have been reported .
Tolerance to the anorectic effect usually develops within a few weeks .
If this occurs , phentermine should be discontinued .
The recommended dose should not be exceeded .
Phentermine may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle .
Risk of abuse and dependence .
The least amount feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage .
Concomitant alcohol use may result in an adverse drug reaction .
Use caution in patients with even mild hypertension ( risk of increase in blood pressure ) .
A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients .
